Popular Articles From: Marriott Vacations Worldwide Corporation Announces Third Quarter 2014 Earnings Release and Conference Call Schedule to New Clinical and Economic Outcome Data for Verigene Blood Culture Test to Be Presented at ICAAC 2014


Marrone Bio Innovations, Inc. (MBI)[NASDAQ:MBII] today announced that, at the recommendation of management, the Audit Committee of its Board of Directors has commenced an internal investigation after management learned of documents calling into question the recognition of revenue in the fourth quarter of 2013 for an $870,000 transaction.
Sign-up for Marrone Bio Innovations Announces Audit Committee Investigation investment picks
--Six consecutive episodes to be distributed exclusively on Marthastewart.com and Aol.com --Talent attached to the contest to include Martha Stewart, Ralph Rucci, Erin Fetherston, Kevin Sharkey, and Kate Berry NEW YORK , Sept.
Sign-up for Shriek Or Chic: Martha's Haute Halloween Challenge New Web Series To Premiere On October 7 investment picks
The award-winning Marvell ARMADA Mobile PXA1088 quad-core platform supports all global broadband 3G standards and enables superior multimedia performance and wireless capabilities for the mass market worldwide SANTA CLARA, Calif.
Sign-up for Samsung Launches New GALAXY Tab 4 7.0 Tablet Powered by Marvell's ARMADA Mobile PXA1088 System-on-Chip investment picks
Matador Resources Company (NYSE: MTDR) (“Matador” or the “Company”), an independent energy company engaged in the exploration, development, production and acquisition of oil and natural gas resources, with an emphasis on oil and natural gas shale and other unconventional plays and with a current focus on its Eagle Ford operations in South Texas and its Permian Basin operations in Southeast New Mexico and West Texas, today is pleased to provide the following update of its ongoing operations.
Sign-up for Matador Resources Company Provides Operational Update and Increases 2014 Oil Production Guidance investment picks
Building upon its legacy of providing curriculum-enriched preschool programming, Nickelodeon will introduce viewers to the exciting world of Science, Technology, Engineering and Math (STEM) with the hour-long premiere of the brand-new, interactive animated series, Blaze and the Monster Machines , on Monday, Oct.
Sign-up for Nickelodeon Launches Blaze and the Monster Machines, Brand-New Preschool Series Supercharged with STEM Curriculum, Monday, Oct. 13, at 12 p.m. (ET/PT) investment picks
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, and ICON plc , (NASDAQ:ICLR) a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced a joint initiative designed to bring new efficiencies to the administration of electronic patient-reported outcomes (ePROs) in clinical trials.
Sign-up for Medidata and ICON Join Forces to Bring New Productivity to Capturing Patient Voice in Clinical Trials investment picks
Approval based on improved overall survival, delayed time to radiographic progression and an overall positive benefit-risk profile TOKYO and SAN FRANCISCO , Sept.
Sign-up for U.S. FDA Approves New Indication for the Use of XTANDI® (enzalutamide) Capsules for Patients with Metastatic Castration-Resistant Prostate Cancer investment picks
HOUSTON, July 25, 2014 (GLOBE NEWSWIRE) -- Memorial Resource Development Corp.
Sign-up for Memorial Resource Development Corp. Announces Second Quarter 2014 Earnings Conference Call and Webcast investment picks
* Net Revenue of $131.8 million, growing 17.5% year-over-year in USD, 65.9% in local currencies BUENOS AIRES, Argentina, Aug.
Sign-up for MercadoLibre, Inc. Reports Financial Results for Second Quarter 2014 investment picks
WHITEHOUSE STATION, N.J. , Sept.
Sign-up for Merck Receives Accelerated Approval of KEYTRUDA® (pembrolizumab), the First FDA-Approved Anti-PD-1 Therapy investment picks
Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT:SAN and NYSE:SNY), announced today that the Biologics License Application (BLA) filed for the companies’ investigational pediatric hexavalent vaccine, DTaP 5 -IPV-Hib-HepB 1 , has been accepted for review by the U.S. Food and Drug Administration (FDA). If approved, it would be the first pediatric combination vaccine in the United States designed to help protect against six important diseases – diphtheria, tetanus, pertussis (whooping cough), polio (poliovirus types 1, 2, and 3), invasive disease caused by Haemophilus influenzae type b (Hib), and hepatitis B.
Sign-up for US FDA Accepts for Review a Biologics License Application for Merck and Sanofi Pasteur’s Investigational Pediatric Hexavalent Vaccine investment picks
Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has designated relebactam (previously known as MK-7655), the company’s investigational beta-lactamase inhibitor, as a Qualified Infectious Disease Product (QIDP) with designated Fast Track status.
Sign-up for Merck’s Investigational Beta-lactamase Inhibitor Relebactam (MK-7655) Granted Qualified Infectious Disease Product (QIDP) and Fast Track Designations by FDA investment picks
ATCHISON, Kan., July 24, 2014 (GLOBE NEWSWIRE) -- The Board of Directors of MGP Ingredients, Inc. (Nasdaq:MGPI) today announced the appointment of beverage alcohol industry executive Gus Griffin as president and CEO of the company effective July 28.
Sign-up for Gus Griffin, Accomplished Beverage Alcohol Industry Exec., Brings Extensive Leadership Experience to Role as New MGP President and CEO investment picks
Shares of Michael Kors Holdings (KORS) slid 5.1% in premarket trade Friday following news that the apparel company's largest shareholder was selling off its stake.
Sign-up for Michael Kors shares slump as major shareholders sell stake investment picks
Microchip Technology Inc. (NASDAQ: MCHP), a leading provider of microcontroller, mixed-signal, analog and Flash-IP solutions, and AZFirst, an Arizona 501(c)3 organization supporting the FIRST ® (For Inspiration and Recognition of Science and Technology) robotics competitions, today announced that Grand Canyon University (GCU) will host the first annual FIRST Arizona West Regional Competition, from April 1-4, 2015, at its Phoenix campus.
Sign-up for Grand Canyon University Selected as Host Site for New 2015 FIRST® Arizona West Regional Robotics Competition investment picks
Microchip Technology Incorporated (NASDAQ:MCHP) NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION Microchip Technology Incorporated (NASDAQ:MCHP), a leading provider of microcontroller, mixed-signal, analog and Flash-IP solutions, today announces that, further to its announcement of August 28, 2014, that it has had preliminary mutual discussions with CSR plc regarding ways in which its relationship with CSR could be advanced, including possibly an acquisition of CSR, any offer for CSR is likely to be solely in cash, although Microchip reserves the right to vary the form of the consideration in any offer if one were to be made.
Sign-up for Microchip Technology Incorporated (“Microchip”) Further Announcement Regarding CSR plc investment picks
Places First for Best New Product of the Year in the Consumer Category; MicroStrategy Also Wins Other Awards TYSONS CORNER, Va.
Sign-up for MicroStrategy Analytics Desktop Wins Gold at Best in Biz Awards 2014 International investment picks
MARIETTA, Ga.
Sign-up for MiMedx To Webcast Its Analyst Day On October 14th investment picks
CHICAGO , Aug.
Sign-up for Morningstar Reports U.S. Mutual Fund Asset Flows for July 2014 investment picks
CHICAGO , Sept.
Sign-up for Morningstar Reports U.S. Mutual Fund and ETF Asset Flows for August 2014 investment picks
Mylan Free to Immediately Resume Distribution of Its Generic Precedex Product PITTSBURGH , Sept.
Sign-up for Court Grants Summary Judgment in Favor of Mylan and FDA Related to Generic Precedex™ investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Popular Articles From: Marriott Vacations Worldwide Corporation Announces Third Quarter 2014 Earnings Release and Conference Call Schedule to New Clinical and Economic Outcome Data for Verigene Blood Culture Test to Be Presented at ICAAC 2014
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent